Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Statistics

Total Valuation

DSE:CENTRALPHL has a market cap or net worth of BDT 982.37 million. The enterprise value is 1.25 billion.

Market Cap	982.37M
Enterprise Value	1.25B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

DSE:CENTRALPHL has 119.80 million shares outstanding. The number of shares has decreased by -2.27% in one year.

Current Share Class	119.80M
Shares Outstanding	119.80M
Shares Change (YoY)	-2.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.67%
Owned by Institutions (%)	n/a
Float	110.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	29.32
PB Ratio	1.20
P/TBV Ratio	1.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-42.25
EV / Sales	37.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.33.

Current Ratio	1.09
Quick Ratio	0.20
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.56% and return on invested capital (ROIC) is -1.69%.

Return on Equity (ROE)	-3.56%
Return on Assets (ROA)	-1.30%
Return on Invested Capital (ROIC)	-1.69%
Return on Capital Employed (ROCE)	-2.75%
Revenue Per Employee	446,741
Profits Per Employee	-394,324
Employee Count	76
Asset Turnover	0.02
Inventory Turnover	2.53

Taxes

Income Tax	-80,248
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.42, so DSE:CENTRALPHL's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-33.33%
50-Day Moving Average	8.76
200-Day Moving Average	9.95
Relative Strength Index (RSI)	40.50
Average Volume (20 Days)	215,459

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:CENTRALPHL had revenue of BDT 33.51 million and -29.57 million in losses. Loss per share was -0.25.

Revenue	33.51M
Gross Profit	-17.63M
Operating Income	-29.65M
Pretax Income	-29.65M
Net Income	-29.57M
EBITDA	-8.32M
EBIT	-29.65M
Loss Per Share	-0.25

Balance Sheet

The company has 1.24 million in cash and 268.47 million in debt, with a net cash position of -267.24 million or -2.23 per share.

Cash & Cash Equivalents	1.24M
Total Debt	268.47M
Net Cash	-267.24M
Net Cash Per Share	-2.23
Equity (Book Value)	815.27M
Book Value Per Share	6.81
Working Capital	31.75M

Cash Flow

Operating Cash Flow	-197,296
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -52.61%, with operating and profit margins of -88.51% and -88.27%.

Gross Margin	-52.61%
Operating Margin	-88.51%
Pretax Margin	-88.51%
Profit Margin	-88.27%
EBITDA Margin	-24.83%
EBIT Margin	-88.51%
FCF Margin	n/a

Dividends & Yields

DSE:CENTRALPHL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.27%
Shareholder Yield	2.27%
Earnings Yield	-3.01%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 26, 2018. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 26, 2018
Split Type	Forward
Split Ratio	1.05

Scores

DSE:CENTRALPHL has an Altman Z-Score of 0.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.14
Piotroski F-Score	2